Subscribe Register Login
Friday, April 20, 2018, 12:15 a.m.

This exclusive story is reserved for our subscribers.

Support independent journalism by subscribing to the Arkansas Democrat-Gazette.

Subscribe now to continue reading.

Favor for firm in fiscal deal

Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world’s largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the “fiscal cliff” bill that did not mention the company by name but strongly favored one of its drugs.

Click here to login or subscribe below.

BEST DEAL
7-Day
Home Delivery
& Online
Online Only
Get Started Get Started
Breaking News
Commenting
Newspaper Content Online
Smartphone Access
Tablet App (iPad) Access
Home Delivery
Sunday Comics, Ad Inserts, Coupons